Publisher
Springer Nature Singapore
Reference89 articles.
1. Acharya, K. P., Ghimire, T. R., & Subramanya, S. H. (2021). Access to and equitable distribution of COVID-19 vaccine in low-income countries. NPJ Vaccines, 6(54), 1–3. https://doi.org/10.1038/s41541-021-00323-6
2. Actionaid. (2021, September 15). Pharmaceutical companies reaping immoral profits from COVID vaccines yet paying low tax rates. Actionaid International. Viewed February 27, 2022. https://actionaid.org/news/2021/pharmaceutical-companies-reaping-immoral-profits-covid-vaccines-yet-paying-low-tax-rates
3. Aguilera, R. V., & Vadera, A. K. (2008). The dark side of authority: Antecedents, mechanisms, and outcomes of organizational corruption. Journal of Business Ethics, 77, 431–449. https://doi.org/10.1007/s10551-007-9358-8
4. Auby, J.-B., Breen, E. B., & Perroud, T. (Eds.). (2014). Corruption and conflicts of interest. https://doi.org/10.4337/9781781009352
5. Bloom, D. E., Cadarette, D., Ferranna, M., Hyer, R. N., & Tortorice, D. L. (2021). How new models of vaccine development for COVID-19 have helped address an epic public health crisis. Health Affairs, 40(3), 410–418. https://doi.org/10.1377/hlthaff.2020.02012